SENS announcements will only be displayed 15 mins after being released by the JSE.

Filter by period:      From:           To:   


Date Headline/Title
17 December 2024 Dealings in securities by prescribed officer
12 December 2024 Acceptance of awards by executive directors, prescribed officers and company secretary
09 December 2024 Update on the acquisition of an interest in Maziv by Vodacom
09 December 2024 Acceptance of awards by executive directors, prescribed officers and company secretary
29 November 2024 Update on the acquisition of an interest in Maziv by Vodacom
29 November 2024 Report on proceedings at the annual general meeting
26 November 2024 Update on the acquisition of an interest in Maziv by Vodacom
22 November 2024 Summary of Manta Bidco Limited results for the six months ended 30 September 2024
15 November 2024 Censure imposed by the JSE against Ms Thabi Leoka, former director of Remgro Limited
15 November 2024 CANCELLATION OF S497307 Censure imposed against Ms Thabi Leoka, former director of Remgro Limited
01 November 2024 Dealings in securities by executive director
31 October 2024 Availability of Integrated Annual Report and Notice of Annual General Meeting
29 October 2024 Update on the acquisition of an interest in Maziv by Vodacom
11 October 2024 Change to company secretary
08 October 2024 Dealings in securities by executive directors
30 September 2024 Availability of Broad-Based Black Economic Empowerment compliance report
27 September 2024 Dealings in securities by an associate of a non-executive director
19 September 2024 Summary of audited results for the year ended 30 June 2024 and cash dividend declaration
18 September 2024 Changes to the board of directors
21 June 2024 Summary of Mediclinic Group Limited results for the year ended 31 March 2024
14 June 2024 Change in function of directors
03 June 2024 Dealings in securities by a director
02 May 2024 Dealings in securities by a director
05 April 2024 Change to the board of directors of Remgro
05 April 2024 Dealings in securities by an independent non-executive director
27 March 2024 Dealings in securities by an executive director and prescribed officer
19 March 2024 Summary of unaudited results for the six months ended 31 December 2023 and cash dividend declaration
15 March 2024 Summary of Mediclinic results for the six months ended 30 Sept 2023 and outlook for the year ending 31 Mar 2024
11 March 2024 Trading statement for the six months ended 31 December 2023
25 January 2024 Disclosure of significant holding of Remgro ordinary shares